Active	Status	Sponsor type	Region	Phase	Filter
2 Active 13 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
gao, chuanyu
NCT04308551: Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease	Not yet recruiting	N/A	594	NA	Indobufen, Aspirin	Henan Institute of Cardiovascular Epidemiology	Stable Coronary Heart Disease	12/22	12/22
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System	Not yet recruiting	N/A	2150	RoW	Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy	Lepu Medical Technology (Beijing) Co., Ltd.	Coronary Heart Disease	01/26	01/28
Huang, Jiguang
No trials found